DELENEX THERAPEUTICS
Delenex Therapeutics AG is a Swiss biotech company developing therapeutic antibody fragments targeting serious medical diseases with high unmet need. The company's fragments are being designed for local/topical application by using the benefits of an antibody therapy with only limited systemic exposure. Its clinically validated technology delivers antibodies exhibiting the highest affinity, solubility and stability all combined with a very low risk of immunogenicity.
DELENEX THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Medical Device Therapeutics
Founded:
2009-01-01
Address:
Zürich, Zurich, Switzerland
Country:
Switzerland
Website Url:
http://www.delenex.com
Total Employee:
1+
Status:
Active
Contact:
41 44 730 51 80
Total Funding:
41.3 M USD
Technology used in webpage:
SPF Amazon Amazon Frankfurt Region
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
LevOss
LevOss is developing a biodegradable material (polymer) embedded with a Nano mesh.
Panoptes Pharma
Developing innovative small molecule drugs to treat eye diseases with high unmet medical need.
Resistentia Pharmaceuticals
Resistentia Pharmaceuticals develops immunotherapeutic products for allergic asthma and inflammatory disorders.
Spero Therapeutics
Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.
Current Advisors List
Current Employees Featured
Founder
Investors List
SV Health Investors
SV Health Investors investment in Venture Round - Delenex Therapeutics
Novo Holdings
Novo Holdings investment in Series A - Delenex Therapeutics
SV Health Investors
SV Health Investors investment in Series A - Delenex Therapeutics
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Series A - Delenex Therapeutics
VI Partners
VI Partners investment in Series A - Delenex Therapeutics
BioMedPartners
BioMedPartners investment in Series A - Delenex Therapeutics
SV Health Investors
SV Health Investors investment in Series A - Delenex Therapeutics
Novo Ventures
Novo Ventures investment in Series A - Delenex Therapeutics
BioMedPartners
BioMedPartners investment in Series A - Delenex Therapeutics
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Series A - Delenex Therapeutics
Official Site Inspections
http://www.delenex.com
- Host name: ec2-13-56-33-8.us-west-1.compute.amazonaws.com
- IP address: 13.56.33.8
- Location: San Jose United States
- Latitude: 37.3388
- Longitude: -121.8914
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 95141
